v3.26.3
Reportable segment - Schedule of Reconciliation of Consolidated Segment (Details) - USD ($)
6 Months Ended 12 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Dec. 31, 2025
Dec. 31, 2024
Operating Segments [Member]        
Revenues:        
Total revenues $ 3,441,177 $ 2,252,805 $ 14,618,184 $ 10,421,352
Cost of revenues 2,507,612 827,523 7,262,219 3,243,772
Segment gross margin 933,565 1,425,282 7,355,965 7,177,580
Compensation and related benefits 898,516 941,043 5,849,235 [1] 4,628,092 [1]
General and administrative 4,391,908 3,587,372 6,495,530 [1] 4,252,531 [1]
Interest expense 172,643 916,974    
Other segment items, net [2] (190,534) 1,507,727    
Income tax expense 5,260 15,233    
Segment operating loss (4,344,228) (5,543,067) (4,988,800) [1] (58,471,253) [1]
Operating Segments [Member] | Patient fees [Member]        
Revenues:        
Total revenues 1,482,432 1,187,036 3,377,536 1,207,343
Operating Segments [Member] | Telehealth Fees [Member]        
Revenues:        
Total revenues 1,958,745 1,063,269 3,862,628 1,003,510
Operating Segments [Member] | Institutional Fees [Member]        
Revenues:        
Total revenues   2,500 2,500 6,880
Segment Reporting, Reconciling Item, Corporate Nonsegment [Member]        
Revenues:        
Interest expense     (2,811,861) (211,459)
Income tax expense     $ (14,644,424) $ (59,344,916)
Income (loss) from discontinued operations, net of tax 2,591,239 (1,029,656)    
Net loss $ (1,752,989) $ (6,572,723)    
[1] The significant expense categories and amounts align with the segment-level information that is regularly provided to the CODM.
[2] Other segment items, net includes Other income, net, Change in fair value of financial instruments, Gain on extinguishment of financial instruments and financial liabilities, and loss on issuance of financial instruments.